Skip to main content
. 2013 Feb;60(2):196–203. doi: 10.1002/pbc.24265

Fig 1.

Fig 1

Estimates of survival for children financed by the Fund for Protection against Catastrophic Expenditures by type of cancer. A: Children with hematologic malignancies (n = 2,489). The 3-year survival rates (KM and 95% CI) were: ALL 50% (40.3–59), AML 30.5% (22.8–38.5), Hodgkin lymphoma 74.5% (64.5–82.1), and non-Hodgkin lymphoma 40.1% (25.1–54.6). Log-rank test, P < 0.0001. B: Children with solid tumors (n = 1,332). The 3-year survival rates (KM and 95% CI) were: CNS tumors 32.8% (19.2–47.1), Renal tumors 58.4% (43.0–70.9), Bone tumors 33.4% (23.4–43.7), Retinoblastoma 59.2% (46.1–70.1), and others solid tumors 52.6% (40.7–63.1). Log-rank test, P < 0.0001.